Repatha and Lamotrigine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repatha (evolocumab) and Lamotrigine (lamotrigine). Common drug interactions include amnesia among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Repatha and Lamotrigine. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,258 Repatha users. Check the latest studies of Repatha.

What is Lamotrigine?

Lamotrigine has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 76,638 Lamotrigine users. Check the latest studies of Lamotrigine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

29 people who take Repatha and Lamotrigine together, and have interactions are studied.

Repatha and Lamotrigine drug interactions.

What are the common drug interactions of Repatha and Lamotrigine, by gender? *:

female:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Aphasia (damage to the parts of the brain that control language)
  3. Blindness
  4. Blood calcium increased
  5. Fatigue (feeling of tiredness)
  6. Migraine (headache)
  7. Heart rate decreased
  8. Arrhythmia (irregular heartbeat)
  9. Brain injury
  10. Colitis ulcerative (inflammation of colon with ulcer)

male:

  1. Death
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Injection site swelling
  4. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  5. Dizziness postural
  6. Drug ineffective
  7. Fatigue (feeling of tiredness)
  8. Hypersomnia (excessive daytime sleepiness (eds))
  9. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  10. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)

What are the common drug interactions of Repatha and Lamotrigine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Death
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

50-59:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Aphasia (damage to the parts of the brain that control language)
  3. Blindness
  4. Blood calcium increased
  5. Fatigue (feeling of tiredness)
  6. Migraine (headache)
  7. Flushing (the warm, red condition of human skin)
  8. Pruritus (severe itching of the skin)
  9. Rash
  10. Skin burning sensation

60+:

  1. Death
  2. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  3. Eye pruritus (eye itching)
  4. Eye swelling
  5. Fatigue (feeling of tiredness)
  6. Frequent bowel movements
  7. Gastric disorder (disease of stomach)
  8. Hallucination, visual (seeing things that aren't there)
  9. Hospitalisation
  10. Hypersomnia (excessive daytime sleepiness (eds))

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 17.24%
  2. High Blood Pressure: 5 people, 17.24%
  3. Atherosclerosis (disorder of the arteries): 4 people, 13.79%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.34%
  5. Depression: 3 people, 10.34%
  6. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 6.90%
  7. Heart Disease: 2 people, 6.90%
  8. Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 2 people, 6.90%
  9. Gastric Ph Decreased: 2 people, 6.90%
  10. Fungal Infection: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Repatha and Lamotrigine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Repatha and Lamotrigine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Repatha:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lamotrigine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Repatha and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lamotrigine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on evolocumab and lamotrigine (the active ingredients of Repatha and Lamotrigine, respectively), and Repatha and Lamotrigine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: